Aerie Pharmaceuticals (United States)
Aerie Pharmaceuticals was an American clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Aerie Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
67%
Total
Publications
60
Total Open
Publications
40
Total
Citations
3.4K
Open Access
Percentage
67%
Total
Publications
60
Total Open
Publications
40
Total
Citations
3.4K
Breakdown
Publisher Open
23%
Both
32%
Other Platform Open
12%
Closed
33%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 18%
6
Hybrid 64%
21
No Guarantees 18%
6
Other Platform Open
Domain 85%
22
Institution 19%
5
Other Internet 12%
3
Preprint 8%
2
Public 4%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 22 |
DOI | Other Internet | 3 |
Imperial College London | Institution | 2 |
doaj.org OAI-PMH Repository | Institution | 2 |
bioRxiv | Preprint | 2 |
University of Ulster | Institution | 1 |
Indiana University | Institution | 1 |
Figshare | Public | 1 |
California Digital Library | Institution | 1 |